Skip to content

Clinical trials

Inflammation trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Country / region: Argentina Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20161
20204
20211
20231
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Enrolling by invitation2
Recruiting2
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S3
AstraZeneca2
Hospital Nacional Profesor Alejandro Posadas2
ARCA Biopharma, Inc.1
Centro de estudios en Cardiologia Intervencionista1
Federal University of São Paulo1
Hospital Provincial de Rosario1
Hospital de Clinicas José de San Martín1
MultiplAI Health Limited1
Windward Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation14
Acute Coronary Syndrome2
Arthritis, Rheumatoid2
COVID-192
Hyponatremia2
Thrombosis2
Asthma1
Atherosclerosis1
Breast Neoplasms1
Coronary Artery Disease1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.